|
Volumn 37, Issue 4, 2005, Pages 1795-1796
|
Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATININE;
GLICLAZIDE;
INSULIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
STEROID;
TACROLIMUS;
ADULT;
ARTHRALGIA;
CADAVER DONOR;
CLINICAL ARTICLE;
CLINICAL OBSERVATION;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DIABETES MELLITUS;
DRUG WITHDRAWAL;
FEMALE;
GRAFT DYSFUNCTION;
HUMAN;
KIDNEY BIOPSY;
KIDNEY DONOR;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
MALE;
MYALGIA;
PANCREAS BIOPSY;
PANCREAS TRANSPLANTATION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RECIPIENT;
RECURRENT DISEASE;
SAFETY;
SARCOIDOSIS;
SURGICAL PATIENT;
TIME;
TREATMENT FAILURE;
WITHDRAWAL SYNDROME;
ADULT;
CREATININE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
GLOMERULAR FILTRATION RATE;
GLUCOCORTICOIDS;
GRAFT REJECTION;
HUMANS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
SAFETY;
TACROLIMUS;
TIME FACTORS;
|
EID: 20344406002
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.02.094 Document Type: Conference Paper |
Times cited : (8)
|
References (5)
|